Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca    AZN   GB0009895292

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

AstraZeneca Buys Back 318283 Shares

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/30/2012 | 12:23pm CEST

AstraZeneca PLC (>> AstraZeneca plc) said Monday it has purchased 318,283 ordinary shares on April 27 at a price of 2666 pence per share for cancellation.

-Shares at 1005 GMT up 1%, at 2704 pence, valuing the company at GBP34 billion.

-By Mark Shapland, Dow Jones Newswires; +44 207 8429358; [email protected]

Stocks mentioned in the article : AstraZeneca plc
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ASTRAZENECA
06/26DJASTRAZENECA : ADRs End Mostly Higher
06/23 TESARO INC (NASDAQ : TSRO) Might Outperform Rivals with Zejula
06/23 ASTRAZENECA : Faslodex CHMP positive opinion in 1L breast cancer
06/23 ASTRAZENECA : Faslodex (fulvestrant) receives positive CHMP opinion for use in 1..
06/22 REPORTS FROM ASTRAZENECA ADD NEW DAT : ...
06/22 INVESTIGATORS AT ASTRAZENECA ZERO IN : DLBCL, NHL and...
06/22 ASTRAZENECA : Studies from AstraZeneca Update Current Data on Inflammation (Iden..
06/22 TROVAGENE : Enters Into Agreement with AstraZeneca to Utilize Trovera® ctDNA Tes..
06/22 China Medical City incubator attracts UK interest
06/22 ASTRAZENECA : Clinical trial deems AstraZenecas Lynparza better for mutation-cau..
More news
Sector news : Pharmaceuticals - NEC
09:22a COVESTRO : vows to cash out to shareholders if no takeover on cards
04:55a MYLAN : Investors call on Mylan chairman, director to step down
06/28 UK blue chips led lower by Hargreaves as strong pound takes toll
06/28DJVECTURA : In Asthma Collaboration With Novartis's Sandoz
06/28DJGLAXOSMITHKLINE : Announces US Filing For Mepolizumab
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
06/23 European Ad Com backs expanded use of AstraZeneca's breast cancer med Faslode..
06/22 AstraZeneca (AZNCF)Presents At JP Morgan European Healthcare Conference - Sli..
06/22 Drug stocks rally on GOP draft of healthcare bill
06/22 Only Bristol Bucks Big Pharma's Drive For External Reliance
06/21 AstraZeneca (AZN) Presents At 2017 Wells Fargo West Coast Energy Conference -..
Advertisement
Financials ($)
Sales 2017 21 493 M
EBIT 2017 5 890 M
Net income 2017 2 622 M
Debt 2017 12 464 M
Yield 2017 4,03%
P/E ratio 2017 31,55
P/E ratio 2018 25,11
EV / Sales 2017 4,53x
EV / Sales 2018 4,42x
Capitalization 84 989 M
More Financials
Chart ASTRAZENECA
Duration : Period :
AstraZeneca Technical Analysis Chart | AZN | GB0009895292 | 4-Traders
Full-screen chart
Technical analysis trends ASTRAZENECA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 34
Average target price 67,6 $
Spread / Average Target -0,23%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Pam P. Cheng Executive VP-Operations & Information Technology
Marc Dunoyer Chief Financial Officer & Executive Director
Sean Bohen Chief Medical Officer & Executive Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA18.08%84 989
JOHNSON & JOHNSON17.19%360 489
ROCHE HOLDING LTD.8.34%226 454
NOVARTIS11.74%223 476
PFIZER3.91%200 985
MERCK AND COMPANY10.68%178 223
More Results